v3.25.2
Equity - Changes in Total Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period   $ 3,823     $ 3,823  
Net income attributable to Ingredion $ 196   $ 148   393 $ 364
Net income (loss) attributable to non-controlling interests 2   2   4 4
Other comprehensive (loss)         133 (62)
Balance at end of period 4,218       4,218  
Increase (Decrease) in Temporary Equity            
Share-based payments subject to redemption, beginning balance 42 60 43 $ 55 60 55
Share-based compensation, net of issuance 9 (18) 7 (12) (9) (5)
Share-based payments subject to redemption, ending balance 51 42 50 43 51 50
Redeemable non-controlling interests, beginning balance 8 7 42 43 7 43
Net income attributable to non-controlling interests 0   (1)     (1)
Fair market value adjustment to non-controlling interests     6     6
Purchases of non-controlling interests     (40)     (40)
Other comprehensive (loss) (1) 1   (1) 0 (1)
Redeemable non-controlling interests, ending balance $ 7 $ 8 $ 7 $ 42 7 7
Dividends declared (in dollars per share) $ 0.80 $ 0.80 $ 0.78 $ 0.78    
Common Stock            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period $ 1 $ 1 $ 1 $ 1 1 1
Balance at end of period 1 1 1 1 1 1
Additional Paid-In Capital            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period 1,158 1,152 1,146 1,146 1,152 1,146
Share-based compensation, net of issuance 2 6 1   8 1
Fair market value adjustment to non-controlling interests     (6)     (6)
Balance at end of period 1,160 1,158 1,141 1,146 1,160 1,141
Treasury Stock            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period (1,393) (1,355) (1,179) (1,207) (1,355) (1,207)
Repurchases of common stock, net   (55) (65) (1) (55) (66)
Share-based compensation, net of issuance 2 17 11 29 19 40
Balance at end of period (1,391) (1,393) (1,233) (1,179) (1,391) (1,233)
Accumulated Other Comprehensive Loss            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period (1,025) (1,086) (1,062) (1,056) (1,086) (1,056)
Other comprehensive (loss) 72 61 (56) (6) 133 (62)
Balance at end of period (953) (1,025) (1,118) (1,062) (953) (1,118)
Retained Earnings            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period 5,236 5,092 4,818 4,654 5,092 4,654
Net income attributable to Ingredion 196 197 148 216 393 364
Dividends declared (52) (53) (52) (52) (105) (104)
Balance at end of period 5,380 5,236 4,914 4,818 5,380 4,914
Non- Redeemable Non- Controlling Interests            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period 21 19 16 14 19 14
Net income (loss) attributable to non-controlling interests 2 2 3 2 4 5
Dividends declared (2)   (2)   (2) (2)
Balance at end of period $ 21 $ 21 $ 17 $ 16 $ 21 $ 17